Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FB3LC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,886
Award facts
- Contract value 100% obligated
- $13,886.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $13,886.00 by the Defense Logistics Agency (DLA) on September 17, 2025. The contract, which carries no set-aside designation, calls for the delivery of Nexplanon 68 mg implants with an ultimate completion date of October 8, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting Department of Defense healthcare facilities worldwide.
The DLA, which manages supply chain operations for military installations globally, leverages this indefinite delivery contract structure to efficiently fulfill pharmaceutical needs across the defense healthcare system. DMS Pharmaceutical Group has established itself as a critical supplier within this framework, consistently securing delivery orders for diverse pharmaceutical products ranging from contraceptive devices to oncology treatments and specialty medications. The Nexplanon implant delivery under this contract supports the medical supply requirements of military health facilities, with performance based in Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DB25FB3LC?
SPE2DB25FB3LC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FB3LC worth?
The government has obligated $13,886 on SPE2DB25FB3LC.
Is contract SPE2DB25FB3LC an order under another contract?
Yes. SPE2DB25FB3LC is a delivery order under SPE2DB20D9761, an indefinite delivery contract.
Was contract SPE2DB25FB3LC competed?
The extent of competition for SPE2DB25FB3LC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award